Latest news with #AmineStaali
Zawya
06-03-2025
- Health
- Zawya
ProvenMed secures Livv trademark
Livv® is the first home diagnostics platform in the region, seamlessly integrating our AI-powered digital lab, accessible through our mobile app, with affordable smart test kits for comprehensive health monitoring. This end-to-end solution transforms personal healthcare by providing instant results, making real-time diagnostics effortless and accessible from home. Livv®'s AI-powered digital lab analyzes tests in real-time, providing users with accurate, actionable insights. "The trademark registration solidifies our brand identity, protecting our innovation and further establishing Livv® as a leader in AI-driven health diagnostics," said Co-founder, Souheil Guessoum. "Granting Livv® exclusive rights to its brand identity, ensuring legal protection and market recognition across its product offerings. This registration affirms the brand's long-term vision and leadership in the digital health sector," said CEO, Amine Staali. About Livv® Livv® is an innovative health-tech solution developed by ProvenMed, specializing in AI-driven wellness technology. It offers at-home smart test kits and access to AI-powered digital labs, enabling individuals to monitor their wellness conveniently. By providing real-time test results and personalized insights, Livv® empowers users to take proactive control of their well-being. About ProvenMed ProvenMed is a pioneering MedTech company dedicated to developing cutting-edge solutions for personal healthcare. Through solutions like Livv®, ProvenMed combines technology with user-centric health innovations, making health tracking more intuitive and effective. For more information, visit Contact: info@
Zawya
30-01-2025
- Health
- Zawya
ProvenMed unveils LIVV at Arab Health 2025
Dubai, UAE – ProvenMed has officially launched LIVV, its cutting-edge AI-powered Digital Home Lab, at Arab Health 2025, drawing significant attention from healthcare professionals, industry leaders, and investors. LIVV is designed to empower individuals with fast, accurate at-home urine analysis, enabling early detection of urinary tract infections (UTIs), ketone levels, kidney health, and overall wellness. By reducing unnecessary clinic visits, LIVV enhances preventive healthcare and expands access to digital health solutions. 'The overwhelming response to LIVV at Arab Health 2025 reaffirms the urgent need for accessible, AI-driven home diagnostics,' said Amine Staali, CEO of ProvenMed. 'This is just the beginning—LIVV represents a major step toward transforming how people take agency over their health and know their body needs before it is too late.' Souheil Guessoum, Co-Founder of ProvenMed, added, 'LIVV marks a pivotal moment for ProvenMed. It's not just about simplifying diagnostics; it's about giving individuals the power to make informed decisions about their health earlier and more proactively. We're excited to see the positive impact LIVV will have on people's lives globally.' Building on this momentum, ProvenMed is actively engaging in strategic partnerships to drive LIVV's global expansion, ensuring that advanced at-home health monitoring becomes the new standard. For media inquiries or partnership opportunities, please contact: ProvenMed PR@
